Clinico-Pathological Association of Haemoglobin At The Time of Presentation: A Predictive Tool of Survivorship in COVID-19

Imran Samee Warraich; Irfan Khan; Muhammad Abid; Sarah Fatimah; Zareen Irshad; Saima Hanif

doi:10.51253/pafmj.v72i1.5840

Authors

Imran Samee Warraich Combined Military Hospital Hyderabad/National University of Medical Sciences (NUMS) Pakistan
Irfan Khan Combined Military Hospital Hyderabad/National University of Medical Sciences (NUMS) Pakistan
Muhammad Abid Combined Military Hospital Hyderabad/National University of Medical Sciences (NUMS) Pakistan
Sarah Fatimah Combined Military Hospital Hyderabad/National University of Medical Sciences (NUMS) Pakistan
Zareen Irshad Jinnah Sindh Medical University, Karachi Pakistan
Saima Hanif Family Medicine Civil, Hospital Hyderabad

DOI:

https://doi.org/10.51253/pafmj.v72i1.5840

Keywords:

Anemia, COVID-19, Haemoglobin, Haemoglobinopathies

Abstract

Objective: To determine the clinico-pathological association of haemoglobin at the time of presentation as a predictor of survivorship in patients suffering from COVID-19.

Study Design: Prospective observational study.

Place and Duration of Study: Combined Military Hospital Hyderabad Pakistan, from Mar to Sep 2020.

Methodology: Two hundred and four patients who were symptomatic and PCR positive for COVID-19 were included in the study. Informed consent was taken from patients and approval from the institutional ethics committee was obtained. Haemoglobin values were analyzed using SPSS version 22.

Results: In our study, 186 (91.2%) patients survived the disease and 18 (8.8%) patients died. The mortality rate was high in patients who presented with low haemoglobin levels at time of presentation.

Conclusion: This study concluded that hemoglobin level at time of presentation could be a predictor of survivorship.